Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis

Arquivos de Gastroenterologia

Volumn 39, Issue 2, 2002, Pages 123-125

  Moretzsohn, Luciana Dias ^a,b   De Brito, Eliza Maria ^a   Reis, Margareth Souza Ferreira ^a   Coelho, Luiz Gonzaga Vaz ^a   Castro, Luiz de Paula ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Esophagitis, peptic, drug therapy; Gastroesophageal reflux, drug therapy; Pantoprazole; Proton pumps, antagonists inhibitors

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG EFFICACY; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION; ULCER HEALING;

EID: 0036556838     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-28032002000200010     Document Type: Article

References (13)

1. Bardhan KD. The role of proton pump inhibitors in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 1995;9 Suppl 1:15-25.
2. Brunner G, Danz-Nieff H, Athmann C. Comparison of pantoprazole (40 mg SID) versus omeprazole (40 mg SID) in intragastric pH and serum gastrin in healthy volunteers. Gastroenterology 1996;112:A78.
3. Dettner A, Vogt R, Seelaff F, Luhmann R, Schneider A, Fisher R. Low-dose of pantoprazole (20 mg) is effective for relief symptoms and healing of lesions in mild reflux oesophagitis. A randomised double-blind, parallel and multi-centre study. Aliment Pharmacol Ther 1998;12:865-72.
4. Escorrou J, Deprez P, Saggioto A, Geldoff H, Fisher R, Maier C. Maintenence therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. Aliment Pharmacol Ther 1999;13:1481-91.
5. Freston JW, Malagelada JR, Petersen H, McCloy RF. Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 1995;7:577-96.
6. Heading RC. Epidemiology of oesophageal reflux disease. Scand J Gastroenterol 1989;168 Suppl:33-7.
7. Hunt RH. The relantionship between the control of pH and healing and symptom relief in gastroesophageal reflux disease. Aliment Pharmacol Ther 1995;9 Suppl 1:3-7.
8. Labenz J, Peitz U, Lesing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 1997;40:36-41.
9. Moss SF, Arnold R, Tytgat GNS, Spechler SJ, Delle-Fave G, Rosin D, Jensen RT, Modlin IN. Consensus statement for management of gastroesophageal reflux disease. J Clin Gastroenterol 1998;27:6-12.
10. Mussig S, Witzel L. Steady state intragastric pH profile after 40 mg pantoprazole: comparision of morning and evening administration. Gastroenterology 1993;104 Suppl 4:A154.
11. Ramirez-Barba EJ, Dibildox M, Bernal F. Low-dose pantoprazole (20 mg) is effective of treatment of mild reflux oesophagitis. Clin Drug Invest 1999;18:445-51.
12. Van Rensburg CJ, Honiball PJ, Grundling HK, VanZyl JH, Spies SK, Eloff FP, Jimjee AE, Segal I, Bothaj F, Cariem AK, Marks IN, Theron I, Bethke TD. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. Aliment Pharmacol Ther 1996;10:397-401.
13. Van Zyl JH. Grundling HR, Van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fisher R, Bethket T. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomised double-blind, parallel and multi-centre study. Eur J Gastroenterol Hepatol 2000;12:197-202.